{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:56:02Z","timestamp":1783727762816,"version":"3.55.0"},"reference-count":54,"publisher":"Zhejiang University Press","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1631\/jzus.b2300538","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:01:49Z","timestamp":1720688509000},"page":"529-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and outcomes of hospitalized kidney transplant recipients with COVID-19 infection in China during the Omicron wave: a single-center cohort study","\u5728 2019 \u51a0\u72b6\u75c5\u6bd2\u75c5\u66b4\u53d1\u6d41\u884c\u671f\u95f4\u611f\u67d3\u5e76\u4f4f\u9662\u6cbb\u7597\u7684\u80be\u79fb\u690d\u53d7\u8005\u7684\u4e34\u5e8a\u7279\u5f81\u4e0e\u9884\u540e: \u4e00\u9879\u4e2d\u56fd\u5355\u4e2d\u5fc3\u961f\u5217\u7814\u7a76"],"prefix":"10.1631","volume":"25","author":[{"given":"Duo","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rending","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-2630","authenticated-orcid":false,"given":"Jianyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"issue":"18","key":"751_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.15585\/mmwr.mm7218a4","volume":"72","author":"FB Ahmad","year":"2023","unstructured":"Ahmad FB, Cisewski JA, Xu JQ, et al., 2023. COVID-19 mortality update\u2013United States, 2022. MMWR Morb Mortal Wkly Rep, 72(18):493\u2013496. https:\/\/doi.org\/10.15585\/mmwr.mm7218a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"751_CR2","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/TP.0000000000004200","volume":"106","author":"RK Avery","year":"2022","unstructured":"Avery RK, 2022. Update on COVID-19 therapeutics for solid organ transplant recipients, including the omicron surge. Transplantation, 106(8):1528\u20131537. https:\/\/doi.org\/10.1097\/TP.0000000000004200","journal-title":"Transplantation"},{"issue":"1","key":"751_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/TP.0000000000003523","volume":"105","author":"Y Azzi","year":"2021","unstructured":"Azzi Y, Bartash R, Scalea J, et al., 2021. COVID-19 and solid organ transplantation: a review article. Transplantation, 105(1):37\u201355. https:\/\/doi.org\/10.1097\/TP.0000000000003523","journal-title":"Transplantation"},{"issue":"12","key":"751_CR4","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.ekir.2022.09.007","volume":"7","author":"B Berger","year":"2022","unstructured":"Berger B, Hazzan M, Kamar N, et al., 2022. Absence of mortality differences between the first and second COVID-19 waves in kidney transplant recipients. Kidney Int Rep, 7(12):2617\u20132629. https:\/\/doi.org\/10.1016\/j.ekir.2022.09.007","journal-title":"Kidney Int Rep"},{"issue":"2","key":"751_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/infdis\/jiab228","volume":"224","author":"E Bernal","year":"2021","unstructured":"Bernal E, Gimeno L, Alcaraz MJ, et al., 2021. Activating killer-cell immunoglobulin-like receptors are associated with the severity of coronavirus disease 2019. J Infect Dis, 224(2): 229\u2013240. https:\/\/doi.org\/10.1093\/infdis\/jiab228","journal-title":"J Infect Dis"},{"issue":"6","key":"751_CR6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.kint.2020.08.005","volume":"98","author":"S Caillard","year":"2020","unstructured":"Caillard S, Anglicheau D, Matignon M, et al., 2020. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int, 98(6):1549\u20131558. https:\/\/doi.org\/10.1016\/j.kint.2020.08.005","journal-title":"Kidney Int"},{"issue":"1","key":"751_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2020050615","volume":"32","author":"L Chan","year":"2021","unstructured":"Chan L, Chaudhary K, Saha A, et al., 2021. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol, 32(1): 151\u2013160. https:\/\/doi.org\/10.1681\/ASN.2020050615","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"751_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","volume":"47","author":"D Chaudhuri","year":"2021","unstructured":"Chaudhuri D, Sasaki K, Karkar A, et al., 2021. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med, 47(5):521\u2013537. https:\/\/doi.org\/10.1007\/s00134-021-06394-2","journal-title":"Intensive Care Med"},{"issue":"10334","key":"751_CR9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","volume":"399","author":"COVID-19 Excess Mortality Collaborators","year":"2022","unstructured":"COVID-19 Excess Mortality Collaborators, 2022. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020\u201321. Lancet, 399(10334):1513\u20131536. https:\/\/doi.org\/10.1016\/S0140-6736(21)02796-3","journal-title":"Lancet"},{"issue":"12","key":"751_CR10","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1111\/ajt.16804","volume":"21","author":"E Daniel","year":"2021","unstructured":"Daniel E, Sekulic M, Kudose S, et al., 2021. Kidney allograft biopsy findings after COVID-19. Am J Transplant, 21(12): 4032\u20134042. https:\/\/doi.org\/10.1111\/ajt.16804","journal-title":"Am J Transplant"},{"issue":"1","key":"751_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/0886022X.2021.1876730","volume":"43","author":"A Daoud","year":"2021","unstructured":"Daoud A, Alqassieh A, Alkhader D, et al., 2021. Immunosuppression in kidney transplant recipients with COVID-19 infection\u2013where do we stand and where are we heading? Ren Fail, 43(1):273\u2013280. https:\/\/doi.org\/10.1080\/0886022X.2021.1876730","journal-title":"Ren Fail"},{"issue":"13","key":"751_CR12","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.18632\/aging.103579","volume":"12","author":"XY Fang","year":"2020","unstructured":"Fang XY, Li S, Yu H, et al., 2020. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging, 12(13):12493\u201312503. https:\/\/doi.org\/10.18632\/aging.103579","journal-title":"Aging"},{"issue":"8","key":"751_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1681\/ASN.2020040432","volume":"31","author":"EA Farkash","year":"2020","unstructured":"Farkash EA, Wilson AM, Jentzen JM, 2020. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol, 31(8):1683\u20131687. https:\/\/doi.org\/10.1681\/ASN.2020040432","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"751_CR14","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1111\/ajt.16246","volume":"20","author":"A Fav\u00e0","year":"2020","unstructured":"Fav\u00e0 A, Cucchiari D, Montero N, et al., 2020. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: a multicentric cohort study. Am J Transplant, 20(11):3030\u20133041. https:\/\/doi.org\/10.1111\/ajt.16246","journal-title":"Am J Transplant"},{"issue":"2","key":"751_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"JP Gangneux","year":"2022","unstructured":"Gangneux JP, Dannaoui E, Fekkar A, et al., 2022. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med, 10(2):180\u2013190. https:\/\/doi.org\/10.1016\/S2213-2600(21)00442-2","journal-title":"Lancet Respir Med"},{"issue":"10","key":"751_CR16","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1097\/TP.0000000000004254","volume":"106","author":"AO G\u00e9rard","year":"2022","unstructured":"G\u00e9rard AO, Barbosa S, Anglicheau D, et al., 2022. Association between maintenance immunosuppressive regimens and COVID-19 mortality in kidney transplant recipients. Transplantation, 106(10):2063\u20132067. https:\/\/doi.org\/10.1097\/TP.0000000000004254","journal-title":"Transplantation"},{"issue":"1","key":"751_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, et al., 2021. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med, 181(1):41\u201351. https:\/\/doi.org\/10.1001\/jamainternmed.2020.6252","journal-title":"JAMA Intern Med"},{"key":"751_CR18","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.trim.2022.101772","volume":"76","author":"B Hajibaratali","year":"2023","unstructured":"Hajibaratali B, Amini H, Dalili N, et al., 2023. Clinical outcomes of kidney recipients with COVID-19 (COVID-19 in kidney recipients). Transpl Immunol, 76:101772. https:\/\/doi.org\/10.1016\/j.trim.2022.101772","journal-title":"Transpl Immunol"},{"issue":"11","key":"751_CR19","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1111\/ajt.16261","volume":"20","author":"S Hartzell","year":"2020","unstructured":"Hartzell S, Bin S, Benedetti C, et al., 2020. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients. Am J Transplant, 20(11):3149\u20133161. https:\/\/doi.org\/10.1111\/ajt.16261","journal-title":"Am J Transplant"},{"issue":"1","key":"751_CR20","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/eci.13404","volume":"51","author":"S Jimeno","year":"2021","unstructured":"Jimeno S, Ventura PS, Castellano JM, et al., 2021. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur J Clin Invest, 51(1):e13404. https:\/\/doi.org\/10.1111\/eci.13404","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"751_CR21","doi-asserted-by":"publisher","first-page":"e2239","DOI":"10.1002\/rmv.2239","volume":"32","author":"T Klopfenstein","year":"2022","unstructured":"Klopfenstein T, Gendrin V, Kadiane-Oussou NJ, et al., 2022. Tocilizumab in COVID-19 pneumonia: practical proposals based on a narrative review of randomised trials. Rev Med Virol, 32(1):e2239. https:\/\/doi.org\/10.1002\/rmv.2239","journal-title":"Rev Med Virol"},{"issue":"12","key":"751_CR22","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1111\/ajt.16742","volume":"21","author":"D Kremer","year":"2021","unstructured":"Kremer D, Pieters TT, Verhaar MC, et al., 2021. A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: lessons to be learned. Am J Transplant, 21(12):3936\u20133945. https:\/\/doi.org\/10.1111\/ajt.16742","journal-title":"Am J Transplant"},{"issue":"7","key":"751_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41581-020-0305-6","volume":"16","author":"A Kronbichler","year":"2020","unstructured":"Kronbichler A, Gauckler P, Windpessl M, et al., 2020. COVID-19: implications for immunosuppression in kidney disease and transplantation. Nat Rev Nephrol, 16(7):365\u2013367. https:\/\/doi.org\/10.1038\/s41581-020-0305-6","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"751_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41581-022-00570-3","volume":"18","author":"V Mahalingasivam","year":"2022","unstructured":"Mahalingasivam V, Su GB, Iwagami M, et al., 2022. COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nat Rev Nephrol, 18(8):485\u2013498. https:\/\/doi.org\/10.1038\/s41581-022-00570-3","journal-title":"Nat Rev Nephrol"},{"key":"751_CR25","doi-asserted-by":"publisher","first-page":"973030","DOI":"10.3389\/fmed.2022.973030","volume":"9","author":"TH Mallhi","year":"2022","unstructured":"Mallhi TH, Khan YH, Alzarea AI, et al., 2022. Incidence, risk factors and outcomes of acute kidney injury among COVID-19 patients: a systematic review of systematic reviews. Front Med (Lausanne), 9:973030. https:\/\/doi.org\/10.3389\/fmed.2022.973030","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"751_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ekir.2022.01.1072","volume":"7","author":"C Masset","year":"2022","unstructured":"Masset C, Gautier-Vargas G, Cantarovich D, et al., 2022. Occurrence of de novo donor-specific antibodies after COVID-19 in kidney transplant recipients is low despite immunosuppression modulation. Kidney Int Rep, 7(5):983\u2013992. https:\/\/doi.org\/10.1016\/j.ekir.2022.01.1072","journal-title":"Kidney Int Rep"},{"issue":"2","key":"751_CR27","doi-asserted-by":"publisher","first-page":"e14050","DOI":"10.1111\/tid.14050","volume":"25","author":"MA Mendoza","year":"2023","unstructured":"Mendoza MA, Ranganath N, Chesdachai S, et al., 2023. Immunomodulators for severe coronavirus disease-2019 in transplant patients: do they increase the risk of secondary infection? Transpl Infect Dis, 25(2):e14050. https:\/\/doi.org\/10.1111\/tid.14050","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"751_CR28","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1016\/S2468-2667(23)00079-8","volume":"8","author":"L Nab","year":"2023","unstructured":"Nab L, Parker EPK, Andrews CD, et al., 2023. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform. Lancet Public Health, 8(5):e364\u2013e377. https:\/\/doi.org\/10.1016\/S2468-2667(23)00079-8","journal-title":"Lancet Public Health"},{"issue":"12","key":"751_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41581-020-00356-5","volume":"16","author":"MK Nadim","year":"2020","unstructured":"Nadim MK, Forni LG, Mehta RL, et al., 2020. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol, 16(12):747\u2013764. https:\/\/doi.org\/10.1038\/s41581-020-00356-5","journal-title":"Nat Rev Nephrol"},{"key":"751_CR30","volume-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]","author":"National Institutes of Health US","year":"2021","unstructured":"National Institutes of Health (US), 2021. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. National Institutes of Health (US), Bethesda, USA. https:\/\/pubmed.ncbi.nlm.nih.gov\/34003615"},{"issue":"2","key":"751_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.ajkd.2020.09.002","volume":"77","author":"JH Ng","year":"2021","unstructured":"Ng JH, Hirsch JS, Hazzan A, et al., 2021. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis, 77(2):204\u2013215.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2020.09.002","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"751_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/TP.0000000000004151","volume":"106","author":"A Nimmo","year":"2022","unstructured":"Nimmo A, Gardiner D, Ushiro-Lumb I, et al., 2022. The global impact of COVID-19 on solid organ transplantation: two years into a pandemic. Transplantation, 106(7):1312\u20131329. https:\/\/doi.org\/10.1097\/TP.0000000000004151","journal-title":"Transplantation"},{"issue":"11","key":"751_CR33","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1111\/ajt.16314","volume":"20","author":"MR Pereira","year":"2020","unstructured":"Pereira MR, Aversa MM, Farr MA, et al., 2020. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study. Am J Transplant, 20(11):3198\u20133205. https:\/\/doi.org\/10.1111\/ajt.16314","journal-title":"Am J Transplant"},{"issue":"11","key":"751_CR34","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1111\/ajt.16192","volume":"20","author":"MJ P\u00e9rez-S\u00e1ez","year":"2020","unstructured":"P\u00e9rez-S\u00e1ez MJ, Blasco M, Redondo-Pach\u00f3n D, et al., 2020. Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant, 20(11):3182\u20133190. https:\/\/doi.org\/10.1111\/ajt.16192","journal-title":"Am J Transplant"},{"issue":"10285","key":"751_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group, 2021. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10285):1637\u20131645. https:\/\/doi.org\/10.1016\/S0140-6736(21)00676-0","journal-title":"Lancet"},{"key":"751_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","volume":"400","author":"RECOVERY Collaborative Group","year":"2022","unstructured":"RECOVERY Collaborative Group, 2022. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet, 400:359\u2013368. https:\/\/doi.org\/10.1016\/S0140-6736(22)01109-6","journal-title":"Lancet"},{"issue":"10387","key":"751_CR37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0140-6736(23)00510-X","volume":"401","author":"RECOVERY Collaborative Group","year":"2023","unstructured":"RECOVERY Collaborative Group, 2023. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 401(10387):1499\u20131507. https:\/\/doi.org\/10.1016\/S0140-6736(23)00510-X","journal-title":"Lancet"},{"issue":"1","key":"751_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.idnow.2021.06.304","volume":"52","author":"Q Richier","year":"2022","unstructured":"Richier Q, Jachiet V, Bonnemains V, et al., 2022. Tocilizumab and COVID-19: timing of administration assessment. Infect Dis Now, 52(1):31\u201334. https:\/\/doi.org\/10.1016\/j.idnow.2021.06.304","journal-title":"Infect Dis Now"},{"issue":"7","key":"751_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(20)30229-0","volume":"8","author":"C Ronco","year":"2020","unstructured":"Ronco C, Reis T, Husain-Syed F, 2020. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med, 8(7):738\u2013742. https:\/\/doi.org\/10.1016\/S2213-2600(20)30229-0","journal-title":"Lancet Respir Med"},{"issue":"1","key":"751_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/cid\/ciac180","volume":"76","author":"LD Saravolatz","year":"2023","unstructured":"Saravolatz LD, Depcinski S, Sharma M, 2023. Molnupiravir and nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs. Clin Infect Dis, 76(1):165\u2013171. https:\/\/doi.org\/10.1093\/cid\/ciac180","journal-title":"Clin Infect Dis"},{"issue":"12","key":"751_CR41","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.4187\/respcare.08779","volume":"66","author":"AK Singh","year":"2021","unstructured":"Singh AK, Oks M, Husk G, et al., 2021. Impact of timing of tocilizumab use in hospitalized patients with SARS-CoV-2 infection. Respir Care, 66(12):1805\u20131814. https:\/\/doi.org\/10.4187\/respcare.08779","journal-title":"Respir Care"},{"issue":"1","key":"751_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","volume":"98","author":"H Su","year":"2020","unstructured":"Su H, Yang M, Wan C, et al., 2020. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int, 98(1):219\u2013227. https:\/\/doi.org\/10.1016\/j.kint.2020.04.003","journal-title":"Kidney Int"},{"key":"751_CR43","doi-asserted-by":"publisher","first-page":"e068302","DOI":"10.1136\/bmj-2021-068302","volume":"375","author":"S Talic","year":"2021","unstructured":"Talic S, Shah S, Wild H, et al., 2021. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ, 375:e068302. https:\/\/doi.org\/10.1136\/bmj-2021-068302","journal-title":"BMJ"},{"key":"751_CR44","doi-asserted-by":"publisher","first-page":"101724","DOI":"10.1016\/j.eclinm.2022.101724","volume":"55","author":"BWL Tan","year":"2023","unstructured":"Tan BWL, Tan BWQ, Tan ALM, et al., 2023. Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study. eClinicalMedicine, 55:101724. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101724","journal-title":"eClinicalMedicine"},{"issue":"5","key":"751_CR45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/SHK.0000000000001585","volume":"54","author":"D Tatum","year":"2020","unstructured":"Tatum D, Taghavi S, Houghton A, et al., 2020. Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients. Shock, 54(5):652\u2013658. https:\/\/doi.org\/10.1097\/SHK.0000000000001585","journal-title":"Shock"},{"issue":"1","key":"751_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/17476348.2021.1983429","volume":"16","author":"JY Tu","year":"2022","unstructured":"Tu JY, Mo XQ, Zhang XD, et al., 2022. Effects of different corticosteroid therapy on severe COVID-19 patients: a meta-analysis of randomized controlled trials. Expert Rev Respir Med, 16(1):79\u201389. https:\/\/doi.org\/10.1080\/17476348.2021.1983429","journal-title":"Expert Rev Respir Med"},{"key":"751_CR47","doi-asserted-by":"publisher","first-page":"154272","DOI":"10.1016\/j.jcrc.2023.154272","volume":"76","author":"R van Grootveld","year":"2023","unstructured":"van Grootveld R, van der Beek MT, Janssen NAF, et al., 2023. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy. J Crit Care, 76:154272. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154272","journal-title":"J Crit Care"},{"issue":"8","key":"751_CR48","doi-asserted-by":"publisher","first-page":"CD014963","DOI":"10.1002\/14651858.CD014963","volume":"8","author":"C Wagner","year":"2021","unstructured":"Wagner C, Griesel M, Mikolajewska A, et al., 2021. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev, 8(8):CD014963. https:\/\/doi.org\/10.1002\/14651858.CD014963","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"751_CR49","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1111\/ajt.16997","volume":"22","author":"AX Wang","year":"2022","unstructured":"Wang AX, Koff A, Hao DN, et al., 2022. Effect of nirmatrelvir\/ritonavir on calcineurin inhibitor levels: early experience in four SARS-CoV-2 infected kidney transplant recipients. Am J Transplant, 22(8):2117\u20132119. https:\/\/doi.org\/10.1111\/ajt.16997","journal-title":"Am J Transplant"},{"issue":"5","key":"751_CR50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/TP.0000000000004462","volume":"107","author":"A Weiss","year":"2023","unstructured":"Weiss A, Hendrickx R, Stensgaard E, et al., 2023. Kidney transplant and dialysis patients remain at increased risk for succumbing to COVID-19. Transplantation, 107(5): 1136\u20131138. https:\/\/doi.org\/10.1097\/TP.0000000000004462","journal-title":"Transplantation"},{"issue":"6","key":"751_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1681\/ASN.2020030348","volume":"31","author":"M Willicombe","year":"2020","unstructured":"Willicombe M, Thomas D, McAdoo S, 2020. COVID-19 and calcineurin inhibitors: should they get left out in the storm? J Am Soc Nephrol, 31(6):1145\u20131146. https:\/\/doi.org\/10.1681\/ASN.2020030348","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"751_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/CM9.0000000000001538","volume":"135","author":"WJ Zhang","year":"2022","unstructured":"Zhang WJ, Han F, Wu XF, et al., 2022. COVID-19 in the immunocompromised population: data from renal allograft recipients throughout full cycle of the outbreak in Hubei province, China. Chin Med J, 135(2):228\u2013230. https:\/\/doi.org\/10.1097\/CM9.0000000000001538","journal-title":"Chin Med J"},{"issue":"9","key":"751_CR53","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1631\/jzus.B2100344","volume":"22","author":"ZF Zhou","year":"2021","unstructured":"Zhou ZF, Kuang H, Ma YX, et al., 2021. Application of extra-corporeal therapies in critically ill COVID-19 patients. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(9):701\u2013717. https:\/\/doi.org\/10.1631\/jzus.B2100344","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"6","key":"751_CR54","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.eururo.2020.03.039","volume":"77","author":"L Zhu","year":"2020","unstructured":"Zhu L, Gong NQ, Liu B, et al., 2020. Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China. Eur Urol, 77(6):748\u2013754. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.039","journal-title":"Eur Urol"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2300538\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:01:57Z","timestamp":1720692117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2300538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2300538","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Duo LV, Xishao XIE, Qinyun YANG, Zhimin CHEN, Guangjun LIU, Wenhan PENG, Rending WANG, Hongfeng HUANG, Jianghua CHEN, and Jianyong WU declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Zhejiang University (expedition review No. 63 in 2023). The Ethics Committee authorized the informed consent waiver. This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}